MMAE ADC EIA Kit

MMAE ADC EIA Kit
Product Description

This test kit is intended for the quantitative determination of the antibody-MMAE conjugate level in a test specimen. It is useful for preclinical and clinical pharmacology study of MMAE Antibody Drug Conjugate (ADC).

- Samples from tissue/cell culture and serum samples from human, rat, mouse, primate, etc. can be used directly with this kit.

- Both humanized monoclonal antibody-based MMAE-ADC and mouse monoclonal antibody-based MMAE-ADC can be measured with this kit.

Creative Diagnostics

  • US
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Academic/Research
Biopharmaceutical company
Contract Service
Primary activities
Analytical Services
Biopharmaceutical
Clinical Research
Specifications
  • CAS Registry Number
    DEIABL312
  • Details
    Sensitivity
    The analytical sensitivity (LLOD) of this MMAE ADC EIA as determined by the 2 times standard deviation below the mean of B0 on 8 duplicate determinations of zero standard (B0) is approximately 0.0435 μg/mL.
  • Selling Points
    Product Features; This assay has showed that it didn't have any high dose "hook" effect for MMAE ADC levels up to 1,000 μg/mL.

  • Model
    DEIABL312
  • Supplied from
    United States

Creative Diagnostics

  • US
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Academic/Research
Biopharmaceutical company
Contract Service
Primary activities
Analytical Services
Biopharmaceutical
Clinical Research

More Products from Creative Diagnostics (1)

  • Anti-MMAE monoclonal antibody

    Product Anti-MMAE monoclonal antibody

    Monomethyl auristatin E (MMAE) is a synthetic antineoplastic agent. Because of its toxicity, it cannot be used as a drug by itself; instead, it is conjugated to a monoclonal antibody (MAB) that directs it to the cancer cells. In international non-proprietary names for MMAE-MAB conjugates, the name vedotin ...

Creative Diagnostics resources (2)

  • News Creative Diagnostics Announces New Reagents for Bioanalysis of Antibody Drug Conjugates

    Creative Diagnostics has announced a series of new reagent solutions to assist researchers in the bioanalysis of ADCs.

  • Brochure Neutralizing antibodies for infectious diseases

    Creative Diagnostics offers a comprehensive selection of neutralizing antibodies to combat infectious disease pathogens. These antibodies can be utilized in various applications including ELISA assay kits, neutralization experiments, WB, IHC, and other related processes. We can also provide services such as host switching and antibody modification tailored to your specific needs. Our proprietary cloning platform allows us to produce high-quality recombinant versions of these antibodies, which are valuable reagents for vaccine development and diagnostic research.